The effects of hepatitis C virus core protein on the expression of miR-122 in vitro

被引：0
作者：
Sujuan Li
Xiaokang Xing
Qiao Yang
Hangdi Xu
Jiliang He
Zhi Chen
Haihong Zhu
机构：
[1] Zhejiang University,State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Institute of Infectious Diseases, the First Affiliated Hospital, School of Medicine
[2] Zhejiang University,Institute of Environmental Medicine, Medical College
来源：
Virology Journal | / 10卷
关键词：
Sustained Virological Response Rate; Telaprevir; Boceprevir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 240 条
  • [1] Lauer GM(2001)Hepatitis C virus infection N Engl J Med 345 41-52
  • [2] Walker BD(2005)Immunology of hepatitis B virus and hepatitis C virus infection Nat Rev Immunol 5 215-229
  • [3] Rehermann B(2002)Peginterferon alfa-2a plus ribavirin for chronic hepatitis c virus infection N Engl J Med 347 975-982
  • [4] Nascimbeni M(2004)Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose Ann Intern Med 140 346-355
  • [5] Fried MW(2001)Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 958-965
  • [6] Shiffman ML(2011)Boceprevir for untreated chronic HCV genotype 1 infection N Engl J Med 364 1195-1206
  • [7] Reddy KR(2011)Boceprevir for previously treated chronic HCV genotype 1 infection N Engl J Med 364 1207-1217
  • [8] Smith C(2011)Telaprevir for previously untreated chronic hepatitis C virus infetion N Engl J Med 364 2405-2416
  • [9] Marinos G(2011)Telaprevir for retreatment of HCV infetion N Engl J Med 364 2417-2428
  • [10] Goncales FL(2011)Genotype differences in susceptibility and resistance development of hepatitis C virus to protease inhibitors telaprevir (VX-950) and danoprevir (ITMN-191) Hepatology 53 1090-1099
12345678910